These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2423571)

  • 1. The role of antiarrhythmic drugs in sudden cardiac death.
    Hoffman BF; Dangman KH
    J Am Coll Cardiol; 1986 Jul; 8(1 Suppl A):104A-109A. PubMed ID: 2423571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrophysiological evidence that local anesthetics and antiarrhythmic drugs bind to a specific receptor site in cardiac sodium channels: displacement of bupivacaine by lidocaine.
    Clarkson CW; Hondeghem LM
    Proc West Pharmacol Soc; 1984; 27():23-5. PubMed ID: 6093130
    [No Abstract]   [Full Text] [Related]  

  • 3. Symposium on the management of ventricular dysrhythmias. Antifibrillatory versus antiectopic therapy.
    Anderson JL
    Am J Cardiol; 1984 Jul; 54(2):7A-13A. PubMed ID: 6147079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrophysiology and antiarrhythmic actions of E-4031 in the experimental animal model of sudden coronary death.
    Chi LG; Mu DX; Lucchesi BR
    J Cardiovasc Pharmacol; 1991 Feb; 17(2):285-95. PubMed ID: 1709234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anti-arrhythmic drug prevention of sudden cardiac death--the status after the CAST study].
    Seipel L; Kühlkamp V
    Z Gesamte Inn Med; 1992 May; 47(5):189-94. PubMed ID: 1615728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of ventricular fibrillation by dextrorotatory sotalol in a conscious canine model of sudden coronary death.
    Lynch JJ; Coskey LA; Montgomery DG; Lucchesi BR
    Am Heart J; 1985 May; 109(5 Pt 1):949-58. PubMed ID: 3993529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclic adenosine monophosphate, ventricular fibrillation, and antiarrhythmic drugs.
    Podzuweit T; Lubbe WF; Opie LH
    Lancet; 1976 Feb; 1(7955):341-2. PubMed ID: 54744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HBI-3000 prevents secondary sudden cardiac death.
    Lee JY; Lucchesi BR
    J Cardiovasc Pharmacol Ther; 2013 Sep; 18(5):453-9. PubMed ID: 23615576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rationale of therapy in the patient with acute myocardial infarction and life-threatening arrhythmias: a focus on bretylium.
    Lucchesi BR
    Am J Cardiol; 1984 Jul; 54(2):14A-19A. PubMed ID: 6380259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simulated interactions between a Class III antiarrhythmic drug and a figure 8 reentry.
    Seigneuric RG; Chassé JL; Auger P; Bardou A
    Acta Biotheor; 2005; 53(4):265-75. PubMed ID: 16583269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can antiarrhythmic drugs survive survival trials?
    Pratt CM; Waldo AL; Camm AJ
    Am J Cardiol; 1998 Mar; 81(6A):24D-34D. PubMed ID: 9537220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical assessment of antiarrhythmic drugs.
    Lucchesi BR; Lynch JJ
    Fed Proc; 1986 Jul; 45(8):2197-205. PubMed ID: 3720962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiarrhythmic and electrophysiologic effects of bepridil in chronically infarcted conscious dogs.
    Lynch JJ; Montgomery DG; Ventura A; Lucchesi BR
    J Pharmacol Exp Ther; 1985 Jul; 234(1):72-80. PubMed ID: 3874285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Preventive antifibrillatory treatment of sudden cardiac death in acute myocardial infarct].
    Thale J; Gülker H; Hindricks G; Haverkamp W; Pollock B; Buchwalsky R
    Z Kardiol; 1988; 77 Suppl 4():11-22. PubMed ID: 3062962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of antiarrhythmic drugs on the repetitive extrasystole threshold and the ventricular fibrillation threshold.
    Murakawa Y; Toda I; Nozaki A; Kawakubo K; Sugimoto T
    Cardiology; 1989; 76(1):58-66. PubMed ID: 2468414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological therapy in coronary heart disease: prevention of life-threatening ventricular tachyarrhythmias and sudden cardiac death.
    Kochs M; Eggeling T; Hombach V
    Eur Heart J; 1993 Sep; 14 Suppl E():107-19. PubMed ID: 8223747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modification of the electrophysiologic matrix by antiarrhythmic drugs.
    Hoffman BF
    J Am Coll Cardiol; 1985 Jun; 5(6 Suppl):28B-30B. PubMed ID: 3923078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autonomic mechanisms in ventricular fibrillation induced by myocardial ischemia during exercise in dogs with healed myocardial infarction. An experimental preparation for sudden cardiac death.
    Schwartz PJ; Billman GE; Stone HL
    Circulation; 1984 Apr; 69(4):790-800. PubMed ID: 6697463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiarrhythmic agents: the modulated receptor mechanism of action of sodium and calcium channel-blocking drugs.
    Hondeghem LM; Katzung BG
    Annu Rev Pharmacol Toxicol; 1984; 24():387-423. PubMed ID: 6203481
    [No Abstract]   [Full Text] [Related]  

  • 20. Opposite change with ischaemia in the antifibrillatory effects of class I and class IV antiarrhythmic drugs resulting from the alteration in ion transmembrane exchanges related to depolarization.
    Aupetit JF; Bui-Xuan B; Kioueh I; Loufoua J; Frassati D; Timour Q
    Can J Physiol Pharmacol; 2000 Mar; 78(3):208-16. PubMed ID: 10721812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.